Phase 3 solanezumab trials: secondary outcomes in mild Alzheimer’s disease patients - Siemers, ER; Sundell, KL; Carlson, C; Case, M; Sethuraman, G; Liu-Seifert, H (Alzheimers Dement, 2016)